MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$612.33
−0.46%Next report
Analyst consensus
- Next report date
- Oct 28, 2026
- EPS estimate
- $4.45
- Revenue estimate
- $714.3M
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- $4.25
- EPS estimate
- $3.98
- Revenue actual
- $707.3M
- Revenue estimate
- $689.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 12
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.6%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $600
- PT range
- $492 – $692
- Analysts
- 7
2 Buy5 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 23, 2026 | $3.98 | $4.25 | Beat 6.78% | $707.3M |
| Apr 23, 2026 | $3.74 | $4.28 | Beat 14.44% | $706.6M |
| Oct 22, 2025 | $3.53 | $3.86 | Beat 9.35% | $659.9M |
| Jul 21, 2025 | $2.98 | $3.10 | Beat 4.03% | $603.3M |
| Jul 22, 2024 | $2.54 | $2.75 | Beat 8.27% | $528.1M |
| Jul 24, 2023 | $1.91 | $1.93 | Beat 1.05% | $460.9M |
| Feb 13, 2023 | $1.79 | $2.12 | Beat 18.44% | $394.1M |
| Jul 25, 2022 | $1.31 | $1.46 | Beat 11.45% | $351.2M |
| Feb 14, 2022 | $1.25 | $1.32 | Beat 5.60% | $308.6M |
| Feb 15, 2021 | $1.24 | $1.35 | Beat 8.87% | $259.7M |
| Jul 27, 2020 | $0.41 | $0.68 | Beat 65.85% | $205.0M |
| Apr 28, 2020 | $0.75 | $0.80 | Beat 6.67% | $230.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026